Kyntra Bio, Inc.KYNB

$6.70-0.21 (-3.04%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$27M

Micro-cap

-100%

2016 — today

10-Year Price

-98%

2016 — today

52-Week Range

$5.22$12.43

Current $6.70· 21%

Kyntra Bio, Inc. functions as a biopharmaceutical enterprise, encompassing the entire process from the initial discovery and rigorous development of innovative treatments to their ultimate market introduction. The company's scientific focus delves into the complex biology of hypoxia-inducible factors (HIF) and connective tissue growth factors (CTGF). Through this research, Kyntra Bio strives to create groundbreaking therapies aimed at tackling conditions like anemia, various fibrotic disorders, and different forms of cancer. Established by Thomas B. Neff on September 29, 1993, the firm's main offices are situated in San Francisco, California.

Valuation in context

P/E ratio

0.2

Historically pricey

Historically pricey — last 10 years

P/B ratio

-0.9

N/A

Not meaningful — company is unprofitable

FCF Yield

-78.9%

Near historic low

Near historic low — last 10 years

Free · No credit card needed

Get alerted when KYNB is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.